News for Dynavax Technologies Corporation (0IDA.L)

Deep Track Capital, LP, (together with its affiliates, ”œDeep Track” or ”œwe”), one of the largest shareholders of Dynavax Technologies Corporation (NASD

Dynavax Technologies Corporation sees strong Q4 results, with Heplisav-B boosting revenue. Click for my updated look at DVAX and a look ahead.

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look at where Dynavax Technologies Corporation (NASDAQ:DVAX) stands against the ...

PR NewswireEMERYVILLE, Calif., Feb. 25, 2025 EMERYVILLE, Calif., Feb. 25, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercia

Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ETCompany ParticipantsPaul Cox - Vice President,...

The following slide deck was published by Dynavax Technologies Corporation in conjunction with their 2024 Q4 earnings call.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

PR NewswireEMERYVILLE, Calif., Feb. 6, 2025 EMERYVILLE, Calif., Feb. 6, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial

PR NewswireEMERYVILLE, Calif., Jan. 27, 2025 Appoints Emilio Emini and Lauren Silvernail to Board of Directors; Two Directors to Step Down at 2025 Annual M

Data demonstrate superiority of HepB-CpG vaccination over conventional hepatitis B vaccines among people living with HIV

PR NewswireEMERYVILLE, Calif., Nov. 26, 2024 EMERYVILLE, Calif., Nov. 26, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercia

We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we are going to take a look at where Dynavax Technologies Corporation (NASDAQ:DVAX) stands against the other...

Dynavax Technologies Corporation's flagship product, Heplisav-B, continues to increase market share consistently in a growing market. Click for this DVAX update.

Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsPaul Cox - Vice President,...

The following slide deck was published by Dynavax Technologies Corporation in conjunction with their 2024 Q3 earnings call.

Dynavax approves $200 million stock buyback plan

As per Fortune Business Insights’ report, the U.S. hepatitis B vaccine Market share sector attained a worth of USD 2.49 Billion in 2022. Forecasts indicate a promising path, foreseeing a Compound…

In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.